Regulatory & Legal

Nukkleus Inc. completes its acquisition of Star 26 Capital, pivoting to defense tech and aiming to fix critical supply chain issues amid market volatility.

A statewide nonprofit group warns of a perfect storm of politics, donor demands, and capacity gaps. Survival in 2026 depends on adapting—fast.

Beyond oral care, Colgate-Palmolive is reshaping rural India with initiatives in water conservation, digital literacy, and waste management.

The deal adds a major East Coast player to O'Hara's Son's platform, accelerating the private equity-led reshaping of the US commercial roofing industry.

Football legends launch a groundbreaking youth tournament at Disney World, pitting grassroots teams against elite academies in a bid for global inclusion.

As EU regulations tighten, Crowell & Moring adds a top sanctions and ESG lawyer, signaling a strategic push to guide clients through a complex new era.

The eyecare tech firm reports a strong fourth quarter fueled by its TearCare system, even as full-year results show a slight dip. Is this a turning point?

As regulations tighten, Americhem unveils new polymers designed to help medical device makers navigate PFAS bans and enhance device traceability.

Award-winning tech fuses NFC tags, scientific analysis, and blockchain to combat the $70B counterfeit wine market and redefine retail security.

One of the nation's largest health systems is expanding its use of advanced AI and analytics to redefine clinical excellence and whole-person care.

Chulalongkorn University's ER-VIPE simulation game uses VR and AI to teach teamwork, reducing medical errors and improving patient safety outcomes.

Vietnam's FPT is the nation's first to earn the ISO/IEC 42001 AI certification, setting a new benchmark for trust and responsible innovation in the region.

U.S. News reveals the most stable careers for 2026, while a new survey shows what Gen Z interns really want: mentorship and a path to employment.

As NorthWestern Energy preps its 2025 results, investors eye the impact of a major merger, tough rate battles, and big bets on data center growth.

The first-ever Wegovy pill is now available via telehealth platform Ro, offering a cash-pay option that could revolutionize access to weight loss drugs.

As Disc Medicine nears a potential drug launch, its new HR chief hire reveals a critical strategy for navigating biotech's intense talent wars.

The biotech firm faces a delisting threat after its equity turned negative. Can recent funding save its Nasdaq spot and its ambitious drug pipeline?

New rules will soon require frequent certificate renewals. A new partnership aims to help Aussie firms automate, as manual processes become impossible.

A joint investment will renew 715 affordable units, offering immediate relief to residents but highlighting the vast scale of the region's housing crisis.

Accelint has won a key role in the MDA's $151B SHIELD program, signaling a major shift toward AI and autonomous systems in national missile defense.